Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
Authors
Keywords
-
Journal
Frontiers in Molecular Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-15
DOI
10.3389/fnmol.2018.00153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3
- (2018) Zi-Jian Wang et al. CNS Neuroscience & Therapeutics
- The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin
- (2018) Bo Wang et al. NEUROBIOLOGY OF DISEASE
- Contribution of Neuroepigenetics to Huntington’s Disease
- (2017) Laetitia Francelle et al. Frontiers in Human Neuroscience
- Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease
- (2017) Luana Naia et al. JOURNAL OF NEUROSCIENCE
- Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17
- (2017) Yang Yang et al. JOURNAL OF NEUROSCIENCE
- Therapies targeting DNA and RNA in Huntington's disease
- (2017) Edward J Wild et al. LANCET NEUROLOGY
- Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways
- (2017) Nagaraj S. Moily et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels
- (2017) Libo Yu-Taeger et al. NEUROPHARMACOLOGY
- Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
- (2017) Cristina Cariulo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Class I Histone Deacetylases in a “Complex” Environment
- (2017) Christopher J. Millard et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
- (2017) Wojciech J. Szlachcic et al. Frontiers in Molecular Neuroscience
- Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases
- (2017) Fabio Sambataro et al. Frontiers in Molecular Neuroscience
- Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3
- (2017) Yu-Ling Wu et al. Scientific Reports
- Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
- (2016) Anna Rocchi et al. ACTA NEUROPATHOLOGICA
- Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding
- (2016) Maxmore Chaibva et al. BIOPHYSICAL JOURNAL
- Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin
- (2016) Li Lin et al. BRAIN RESEARCH
- Atxn2 Knockout and CAG42-Knock-in Cerebellum Shows Similarly Dysregulated Expression in Calcium Homeostasis Pathway
- (2016) Melanie Vanessa Halbach et al. CEREBELLUM
- Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's diseasein vitromodel
- (2016) Mijung Lee et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Allele-specific regulation of mutantHuntingtinby Wig1, a downstream target of p53
- (2016) Sun-Hong Kim et al. HUMAN MOLECULAR GENETICS
- Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington’s disease
- (2016) Abhishek Chandra et al. HUMAN MOLECULAR GENETICS
- Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization
- (2016) Laura F. DiGiovanni et al. HUMAN MOLECULAR GENETICS
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice
- (2016) Ian H. Kratter et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models
- (2016) Luana Naia et al. MOLECULAR NEUROBIOLOGY
- PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington’s Disease-Associated Phenotypes In Vivo
- (2016) Joseph Ochaba et al. NEURON
- Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models
- (2016) Vahri Beaumont et al. NEURON
- Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways
- (2016) Melissa Ingram et al. NEURON
- Safety and efficacy of valproic acid treatment in SCA3/MJD patients
- (2016) Li-Fang Lei et al. PARKINSONISM & RELATED DISORDERS
- The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53
- (2016) Hongmei Liu et al. PLOS BIOLOGY
- Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach
- (2016) Louise-Laure Mariani et al. JAMA Neurology
- ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation
- (2016) Tina Zimmermann et al. Stem Cell Reports
- Genomic Instability Associated with p53 Knockdown in the Generation of Huntington’s Disease Human Induced Pluripotent Stem Cells
- (2016) Andrew M. Tidball et al. PLoS One
- The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice
- (2016) Haiqun Jia et al. PLoS One
- miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington’s Disease Monkey Neural Cells
- (2016) Tanut Kunkanjanawan et al. PLoS One
- Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model
- (2015) Abiodun Ajayi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation
- (2015) A-ram Kang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
- (2015) Sigurd D. Süssmuth et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD)
- (2015) Tamara Ratovitski et al. CELL CYCLE
- Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway
- (2015) Wojciech J. Szlachcic et al. Disease Models & Mechanisms
- Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor–mediated disease
- (2015) Jason P. Chua et al. JOURNAL OF CLINICAL INVESTIGATION
- Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways
- (2015) Minhee Jang et al. MOLECULAR NEUROBIOLOGY
- Acetylation site specificities of lysine deacetylase inhibitors in human cells
- (2015) Christian Schölz et al. NATURE BIOTECHNOLOGY
- A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease
- (2015) Kristina Bečanović et al. NATURE NEUROSCIENCE
- MicroRNA-124 slows down the progression of Huntington′s disease by promoting neurogenesis in the striatum
- (2015) Manho Kim et al. Neural Regeneration Research
- The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster
- (2015) Wei-Ling Tsou et al. NEUROBIOLOGY OF DISEASE
- Protein Arginine Methyltransferase 6 Enhances Polyglutamine-Expanded Androgen Receptor Function and Toxicity in Spinal and Bulbar Muscular Atrophy
- (2015) Chiara Scaramuzzino et al. NEURON
- Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice
- (2015) Shanshan Huang et al. Cell Reports
- HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation
- (2014) Ulrike Träger et al. BRAIN
- Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms
- (2014) Minhee Jang et al. BRAIN BEHAVIOR AND IMMUNITY
- Pharmacological benefit of I1-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease
- (2014) Surbhi Gupta et al. BRAIN RESEARCH BULLETIN
- Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis
- (2014) Amit Kumar et al. DRUG DISCOVERY TODAY
- Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology
- (2014) Megha Maheshwari et al. HUMAN MOLECULAR GENETICS
- Deactivation of TBP contributes to SCA17 pathogenesis
- (2014) Tun-Chieh Hsu et al. HUMAN MOLECULAR GENETICS
- The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1
- (2014) Anand Venkatraman et al. HUMAN MOLECULAR GENETICS
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- Valproic acid attenuates the suppression of acetyl histone H3 and CREB activity in an inducible cell model of Machado–Joseph disease
- (2014) X.P. Lin et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Transcription, Epigenetics and Ameliorative Strategies in Huntington’s Disease: a Genome-Wide Perspective
- (2014) Luis M. Valor MOLECULAR NEUROBIOLOGY
- Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7
- (2014) Jennifer Y Tan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington’s Disease
- (2014) Joshua L. Plotkin et al. NEURON
- Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones
- (2014) Davide Schiffer et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation
- (2014) Haiqun Jia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A
- (2014) K. P. Bhat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sirtuin 1 activator SRT2104 protects Huntington's disease mice
- (2014) Mali Jiang et al. Annals of Clinical and Translational Neurology
- Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington’s disease
- (2013) Hsin Hsien Yeh et al. BRAIN RESEARCH
- Second Cistron in CACNA1A Gene Encodes a Transcription Factor Mediating Cerebellar Development and SCA6
- (2013) Xiaofei Du et al. CELL
- PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
- (2013) Albert Giralt et al. HIPPOCAMPUS
- A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease
- (2013) Han-Yun Hsiao et al. HUMAN MOLECULAR GENETICS
- Direct Inhibition of Gcn5 Protein Catalytic Activity by Polyglutamine-expanded Ataxin-7
- (2013) Tara L. Burke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lithium Down-regulates Histone Deacetylase 1 (HDAC1) and Induces Degradation of Mutant Huntingtin
- (2013) Shuai Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models
- (2013) Paola Conforti et al. JOURNAL OF NEUROCHEMISTRY
- Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
- (2013) Jing Jin et al. JOURNAL OF NEUROCHEMISTRY
- The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients
- (2013) Robert B. Laprairie et al. JOURNAL OF NEUROIMMUNOLOGY
- Herpes Simplex Virus 1 E3 Ubiquitin Ligase ICP0 Protein Inhibits Tumor Necrosis Factor Alpha-Induced NF-κB Activation by Interacting with p65/RelA and p50/NF-κB1
- (2013) Jie Zhang et al. JOURNAL OF VIROLOGY
- Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation
- (2013) M. Dhruba Singh et al. NEUROBIOLOGY OF DISEASE
- Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4
- (2013) Jiping Yi et al. PLoS One
- Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease
- (2013) Wooseok Im et al. PLoS One
- SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
- (2013) Jacqueline Gire O’Rourke et al. Cell Reports
- PPARGC1A/PGC-1α, TFEB and enhanced proteostasis in Huntington disease
- (2012) Albert R. La Spada Autophagy
- In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice
- (2012) P Conforti et al. GENE THERAPY
- Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2
- (2012) S. T. Hansen et al. HUMAN MOLECULAR GENETICS
- A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset†
- (2012) Selma M. Soyal et al. HUMAN MOLECULAR GENETICS
- Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease
- (2012) Rajnish Kumar Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Sp1 Regulates Human Huntingtin Gene Expression
- (2012) Ruitao Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS
- (2012) Sanjeev Rajakulendran et al. Nature Reviews Neurology
- DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles
- (2012) Kazushi Suzuki et al. NEUROBIOLOGY OF DISEASE
- Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
- (2012) Haiqun Jia et al. NEUROBIOLOGY OF DISEASE
- Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
- (2012) Alessandro Leuti et al. NEUROBIOLOGY OF DISEASE
- SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
- (2012) Anna Bobrowska et al. PLoS One
- Temporal Separation of Aggregation and Ubiquitination during Early Inclusion Formation in Transgenic Mice Carrying the Huntington’s Disease Mutation
- (2012) Belvin Gong et al. PLoS One
- Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes
- (2012) S. D. McCullough et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models
- (2012) Vanita Chopra et al. Cell Reports
- Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment
- (2011) Jun Wu et al. CHEMISTRY & BIOLOGY
- Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model
- (2011) Yi Chun Chen et al. HUMAN MOLECULAR GENETICS
- Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease
- (2011) Ashu Johri et al. HUMAN MOLECULAR GENETICS
- A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome
- (2011) Jie Ren et al. HUMAN MOLECULAR GENETICS
- Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration
- (2011) S. F. Sleiman et al. JOURNAL OF NEUROSCIENCE
- SIRT1 Modulates Aggregation and Toxicity through Deacetylation of the Androgen Receptor in Cell Models of SBMA
- (2011) H. L. Montie et al. JOURNAL OF NEUROSCIENCE
- Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 Contributes to Dysmyelination in Experimental Models of Huntington's Disease
- (2011) Z. Xiang et al. JOURNAL OF NEUROSCIENCE
- Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
- (2011) Hong Van B Che et al. Molecular Neurodegeneration
- Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
- (2011) Mali Jiang et al. NATURE MEDICINE
- Truncated Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Splice Variant Is Severely Altered in Huntington’s Disease
- (2011) Ashu Johri et al. Neurodegenerative Diseases
- SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
- (2011) Michal Mielcarek et al. PLoS One
- Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin
- (2011) A. Grison et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toward understanding Machado–Joseph disease
- (2011) Maria do Carmo Costa et al. PROGRESS IN NEUROBIOLOGY
- Altered microRNAs in STHdhQ111/HdhQ111 cells: miR-146a targets TBP
- (2010) Mithun Sinha et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Downregulation of NF-κB signaling by mutant huntingtin proteins induces oxidative stress and cell death
- (2010) Sami Reijonen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons
- (2010) Hung-Li Wang et al. EXPERIMENTAL NEUROLOGY
- Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
- (2010) Daniel J. Ho et al. EXPERIMENTAL NEUROLOGY
- The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2
- (2010) L. Hallen et al. HUMAN MOLECULAR GENETICS
- The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-κB from the synapse to the nucleus
- (2010) Edoardo Marcora et al. HUMAN MOLECULAR GENETICS
- Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma
- (2010) Ming-Chang Chiang et al. HUMAN MOLECULAR GENETICS
- Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington’s disease
- (2010) Chiara Soldati et al. JOURNAL OF NEUROCHEMISTRY
- Partial Depletion of CREB-Binding Protein Reduces Life Expectancy in a Mouse Model of Huntington Disease
- (2010) Alexandra M. Klevytska et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
- (2010) Elena Puerta et al. NEUROBIOLOGY OF DISEASE
- HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
- (2010) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease
- (2010) Tyisha Hathorn et al. NEUROBIOLOGY OF DISEASE
- p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons
- (2010) An-Hsun Chou et al. NEUROCHEMISTRY INTERNATIONAL
- Transcriptional Activation of REST by Sp1 in Huntington's Disease Models
- (2010) Myriam Ravache et al. PLoS One
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- Analysis of the Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy of Non-Neuronal Genes in Peripheral Lymphocytes from Patients with Huntington's Disease
- (2009) Manuela Marullo et al. BRAIN PATHOLOGY
- Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
- (2009) Hyunkyung Jeong et al. CELL
- Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease
- (2009) Carmela Giampà et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Impaired PGC-1α function in muscle in Huntington's disease
- (2009) Rajnish K. Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model
- (2009) Remko de Pril et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The gene coding for PGC-1α modifies age at onset in Huntington's Disease
- (2009) Patrick Weydt et al. Molecular Neurodegeneration
- Brain-derived neurotrophic factor in neurodegenerative diseases
- (2009) Chiara Zuccato et al. Nature Reviews Neurology
- CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease
- (2009) Yun-Sik Choi et al. NEUROBIOLOGY OF DISEASE
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
- (2009) S. Subramaniam et al. SCIENCE
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
- The polyubiquitinUbcgene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease
- (2008) John S. Bett et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
- (2008) Zena DeMarch et al. NEUROBIOLOGY OF DISEASE
- A microRNA-based gene dysregulation pathway in Huntington's disease
- (2007) Rory Johnson et al. NEUROBIOLOGY OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started